Translating biomarker insights into practice: a path forward in TA-TMA management
Recent advances in the management of transplant-associated thrombotic microangiopathy (TA-TMA) include the harmonization of diagnostic criteria and the identification of high-risk disease features. Individual hematologic and complement biomarkers show moderate specificity when used alone in the dete...
Saved in:
| Main Authors: | Sonata Jodele, Eleni Gavriilaki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1550365/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Time course of organ and hematological response to complement blockage in transplant-associated thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
by: Tatiana A. Rudakova, et al.
Published: (2025-03-01) -
Effective Management of Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma Using Eculizumab
by: Jennifer Kim, et al.
Published: (2025-06-01) -
The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis
by: Armando Martinez Salazar, et al.
Published: (2025-05-01) -
“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Federica Maritati, et al.
Published: (2024-04-01) -
Eculizumab or ravulizumab treatment effect in people with neuromyelitis optica spectrum disorder: a plain language summary of three studies
by: Alfredo Damasceno, et al.
Published: (2025-02-01)